chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a female patient who on 30-JAN-2008 was vaccinated SC with a dose of zoster vaccine live (Oka/Merck) (Lot # 659323/1613U). On 02-FEB-2008 the patient developed an injection site rash. The patient sought unspecified medical attention. At the time of this report, the outcome of the adverse event was unknown. No product quality complaint was involved. Additional information has been requested.
Right became pink initially the next day, the on 3rd day eye sight was compromised by film over eye and throbbing pain behind the eye.  Sight was almost completely impaired.
This case was reported by a physician via call center representative and described the occurrence of neck pain in a 17-year-old female patient who received Bexsero (batch number 16B601, expiry date 1st February 2019) for prophylaxis. On 11th September 2018, the patient received the 2nd dose of Bexsero. On 11th September 2018, less than a day after receiving Bexsero, the patient experienced neck pain, movement disorder, skin warm, back pain and headache. On an unknown date, the outcome of the neck pain, movement disorder, skin warm, back pain and headache were not recovered/not resolved. It was unknown if the reporter considered the neck pain, movement disorder, skin warm, back pain and headache to be related to Bexsero. Additional information was received as follows: The healthcare professional reported that at 3:15 pm, the patient received the dose of Bexsero. By the end of the vaccination day the patient experienced a reaction such as headache, neck ache, backache, warm to touch and difficulty to keeping head up. The healthcare professional would like to know if these were common reactions. The reporter's call was transferred to MES for guidelines.
Patient received vaccines at 12:00 at 14:45 became hoarse and felt like he was having difficulty breathing, also mild cough. Developed flat, red rash on cheeks, arms and legs. Received BENADRYL (375mg) and 15 mg PREDNISONE in office with improvement in symptoms. No wheezing on exam, no facial swelling sent home with BENADRYL q 4-6 x 24 hours and PREDNISONE 15mg 131b x 3 days. 02 sat= 96%  BP= 112/65; HR- 60.
Fever to 102 degrees F within 24 hours.  Red spots around injection site on skin and swelling.  Rash gone 07/11/2003.  Some swelling continues.
Information has been received from a physician concerning a 12 month old female, with no know medical history and no allergies, who on 08-MAR-2007 was vaccinated with a subcutaneous dose of ProQuad (Lot # 653354/0300F). The patient was "healthy without illness" prior to the immunization. Concomitant therapy included TYLENOL and MOTRIN. On 11-MAR-2007, the patient experienced fever over 100.F watery eyes, runny nose and swelling at the injection site (arm). On 12-MAR-2007, the patient was brought into the physician's office and the patient's temperature was 100.3 and there was swelling at the injection site, watery eyes and runny nose. The physician reported the duration of events to be one day. It was reported that the patient recovered. Additional information has been requested.
EE is fully vaccinated as on 1/26/2021 with Pfizer and contracted COVID, tested positive on 9/10/2021
Widespread rash across chest, lower neck, upper abdomen, and front of shoulders. Not raised, not itchy, just slightly warm and mildly tender.
An initial report was received in the USA from another manufacturer HQWYE764517MAY05 on 7/5/05. It was reported that a 3 year old male child was found to have autism that was dx'd in 12/04. He received Act-Hib, (date, lot number, site and route not reported). Exact latency, concomitant medications and past medical history were not provided. The pt's recovery status was reported as unknown.
Severe headache that got worse progressively, chills and sweats . Lasted 2 days. Went to ER the morning after.
begining 28OCT pt devel fever, chills, sore throat, swollen tonsils, spitting up blood; found to have infected tonsils; hospitalized for tonsillectomy; adverse reactions attributed to vax of Td;
I had/have a heart right bundle branch block. My EKG claimed from 420 to almost 500 and anything over 500 I can die of sudden death; I had/have a heart right bundle branch block. My EKG climed from 420 to almost 500 and anything over 500 I can die of sudden death; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 02239709.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ELECTROCARDIOGRAM ABNORMAL (medically significant), BUNDLE BRANCH BLOCK RIGHT (medically significant) all with onset 2021, outcome "unknown" and all described as "I had/have a heart right bundle branch block. My EKG claimed from 420 to almost 500 and anything over 500 I can die of sudden death". The patient underwent the following laboratory tests and procedures: Electrocardiogram: (2021) 420 to almost 500 and anything over 500, notes: My EKG claimed from 420 to almost 500 and anything over 500 I can die of sudden death.  Clinical course: The 2021 Pfizer COVID 19 shot destroyed my heart. I'm basically a dead man walking. I a heart right bundle branch block. My EKG claimed from 420 to almost 500 and anything over 500 1 can die of sudden death. No additional information provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient reports that he took a home COVID-19 test on Saturday that was positive and started feeling bad a few days before that. He has been experiencing nausea/vomiting, loss of taste and smell, and loss of appetite. He is also experiencing cough, chills, fever, myalgias, and headaches. His O2 sat on presentation was 90%. He has been started on dexamethasone and baricitinib and will be admitted to the hospital.
Starting the night of second dose of Moderna COVID vaccine, white oral lesion on right upper palate and right  upper molar pus and erosion of tooth bone developed and lasted for 6 weeks.  Fever present for 3 days.  Fatigue and hot flashes lasted 1 month. Treated with doxycycline with no improvement .  Debridement also done.   Outcome is good. No loss of tooth.  Full recovery.  Cause unknown.
Pt received 12 month MMR during the day of 3/17/07 and by that night he had a temperature of 102.5 and screamed all through the night - also had rash on neck and injection site (lasted for 1 1/2 yrs). He lost all words (5-6) and eye contact within 2 weeks. He has never recovered - Diagnosed with Autism 5/08.   01/07/2009 MR received from PCP from 3/16/07-3/2007. Pt presented for WCC 3/16/07 with Assessment:  Well child-12 months.  Normal 12 month development noted. Vax given.  Pt returned 3/24/07 with c/o rash, fever and "not himself". Heat rash noted on PE. Seen again 4/11/07 for parental concern that pt had change in behavior since 12 month exam, no longer saying mama, dada, wants to play alone, social before, and now a picky eater with screaming at mealtime.  Normal exam. DX:  Feeding problems.  Neuro eval 4/24/07 notes behavior and personality changes and regression of speech.  Seen for 15 month WCC 7/5/07. Developmental exam "No" for several milestones. Loose stools noted.  24 month WCC 3/19/08 with parental concerns re: development, specifically speech. ? Autism. Dx: Development Disorder, speech unspecified. Referred for neuro eval 5/24/07 with sx suggestive of Autism. DX of Autism Spectrum Disorder with GI componant noted in 7/2008. Now receiving PT, OT and Speech Tx.
This spontaneous case reported by a consumer, describes the occurrence of arthralgia (shoulder still hurts) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 011M20A) for COVID-19 immunization. No medical history reported. On Feb 4, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 4, 2021, patient experienced arthralgia (shoulder still hurts). The patient treated with cortisone for shoulder pain, 1 dosage form. At the time of the report, arthralgia (shoulder still hurts) outcome: unknown. mRNA-1273 (Moderna COVID-19 vaccine): dosing remained unchanged. Concomitant medications included steroids.
(R) deltoid area red and warm - approx 3 - 3 1/2" radius. T. 98.6, orally. No adenopathy. Painful upper arm. Tx: symptomatic (pruritis only). F/U redness resolved in few days.
I received a shingles shot on Oct 14, at 8:00 a.m. By 5 pm my arm was swollen and hard and developed a rash 5 3/4 inches by 2 3/4 inches. During the night the pain was shooting down the arm - keeping me awake. I went back to the clinic and was informed that very rarely the shot causes shingles. Was told to use BENADRYL Allergy pills and BENADRYL cream to calm symptoms. The rash and symptoms were present for 10 days, and are now disappearing.
First evening,  fever , chills , shooting pains in stomach , pain in arm , extreme nausea , migraine
Patient stated he developed a rash and itching 3 days after received vaccinations. Patient reported rash disappeared after 24 hours. Itching still remains today; 10/04
Vaccine 5 pm 12/10 Itching 10 pm 12/11 Rash am and all day -12/12 and 12/13 - pt applied BENADRYL cream. Rash was small red dots  chest and back - 12/14 Rash gone but itching continues - 12/14 and 12/15 - pt advised to seek MD care.
c/o lt hip hurting 15SEP95 no redness; 20SEP95 could not stand on foot; MD @ ER MRI showed fluid around joint of hip no fever, rash;
I was a healthy and active 48- year old with no medical conditions and no medications. Fulfilling my civic duty, I received the recommended Covid 19 vaccine, on May 11, 2021 and second dose on June 2, 2021. On June 10, 2021, I had a stroke. I now have to maintain 3-4 different medications to prevent another clotting event, and I am unable to fully use my left arm and left hand/fingers. This damage has impacted my ability to work and my left arm/hand function could be limited for the rest of my life.
Spontaneous Uticaria that comes and goes.  Itching on feet and hands, especially in the evening.  Both seem to be more prevalent at in the evening.   Jumps all round from my neck, my legs, my arms ...basically everywhere.  Large rash where I itch, raised bumps and lines.
9/17/21 pt brought from Rehab (for ORIF right femur) to ED; pt had tested positive for COVID in rehab center on 9/14/21; since then has developed fever, SOB, cough; on O2 supplementation and hypotensive when brought to ED; emphysema; admitted; received monoclonal antibodies 2 days prior to coming to ED; COVID pneumonia; given ABX, decadron, vitamins C & D, zine, Lovenox; DNR; septic shock; pt did not improve and passed away in the hospital
Event occurred after 2nd vaccine. First vaccine was on 2/6/21 and the second one on 3/6/21. Pt tested positive for COVID-19 on  01/03/22.
Fully vaccinated, no booster.   COVID breakthrough infection.  Inpatient hospital stay.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021 at 8:56 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 22-Jun-2021 at 8:56 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The age of patient was provided as 18.98.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  On 22-Jun-2021, Excursion time was 08 AM, temperature was 35, total doses given for the day was 36, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 27-May-2021, vial was moved to clinic on 22-Jun-2021. 04 vials were sent to clinic. Vaccine BUD date was 26-Jun-2021.  On 22-Jun-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: 35, 9 AM: 39, 10 AM: 47, 11 AM: 36, 12 AM: 42, 1PM: 43, 2 PM: 43, 3 PM: 43, 4 PM: 43.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. The temperature recordings were taken by using a Fisher brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.
This is a spontaneous report by a contactable nurse through a Pfizer Sales Representative. This female nurse reported similar events for three different patients. This is the first of three reports. A patient received PREVNAR 13 injection unknown dose as a single shot at unknown time on an unknown anatomical site on an unknown date. Relevant medical history, relevant drug history and relevant concomitant medications were unknown. Vaccine given on the same day was unknown. Vaccines taken within the last four weeks were unknown. In Sep2012 after taking the single shot of PREVNAR 13 the area around the site of injection was warm to touch and had redness and swelling around the site of injection. Relevant lab data was unknown. At the time of the report clinical outcome of the above mentioned events were unknown. Follow-up (19OCT2012): Follow-up attempts completed. No further information expected.
After getting home from reviving vaccine, I noticed my face was red and flushed. It went away within an hour.
Right deltoid developed local reaction, Post pneumococcal, which required physician evaluation, cephalosporin antibiotic and Aleve, and off work until 9/18/06. Recheck 9/18/06 and improved released to work. Stated mother informed her on 9/15/06 that she had previous reaction in childhood to Pneumococcal vaccine.
Patient had asked for a call from the pharmacy when a vaccination became available and was called . Patient failed to remember he already had gotten a dose on 3/27/21 and pharmacy vaccinated patient.
diarrhea; weakness; fatigue; low grade fever/my fever reached 102; body aches; This is a spontaneous report from a contactable Nurse(patient). A 39-year-old female patient received first dose BNT162B2 (lot number EJ1685) , via an unspecified route of administration at Arm Left on 20Dec2020 12:15 at the 39 years old at single dose for COVID-19 immunization.  The medical history included septic shock, from 2014 multi organ failure. There were no known allergies. The concomitant medications were topiramate(TROKENDI), lisdexamfetamine mesylate(VYVANSE), bupropion, sertraline, paracetamol(TYLENOL). On 22Dec2020 12:00 the patient started to have a low grade fever and body aches. On 23Dec2020 12:00 her fever reached 102 Fahrenheit, she had body aches, diarrhea, weakness and fatigue. This continued until 27Dec2020. The patient took Tylenol and Advil for fever. Tylenol and Advil helped some with fever but not always. There was no treatment received for body aches, diarrhea and weakness and fatigue. The events low grade fever, fever reached 102, body aches, diarrhea, weakness and fatigue resulted in Emergency Room Visit. There was no other vaccine in four weeks. The patient had not COVID prior vaccination. The patient had not COVID tested post vaccination. The outcome of the events was recovered on 27Dec2020.
Cramping and gas which lead to diarrhea since vaccine.  More stomach pain,  hot then cold a headache and not hungry on day 3 after vaccine.
Running nose and sore throat. Today is Monday June 14, 2021 still have runny nose and sore throat, no chills.  Had chills in the beginning with runny nose and sore throat.
Presented to ED w/ c/o weakness; EMS report pt tested COVID-19+ x 3 days ago; admitted for COVID-19 pna w/hypoxic resp failure; tx w/abx, Vit C, zinc, O2 therapy; NC weaned to RA; dc'd back to NH
Pain in injection area of pneumococcal vaccine. Medicine collected in injection area in muscle and was not absorbed properly. Continued pain and severe soreness at place of injection. See answer #12.
Headache within 2 hours of receiving vaccine. Headache lasted for two days.; This is a spontaneous report from a non-contactable consumer, the patient. A 51-year-old-non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6204) via an unspecified route of administration in the left arm on 11Mar2021 at 15:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy and adhesive tape allergy. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Mar2021 at 17:30, within 2 hours of vaccination, the patient experienced headache that lasted for two days. The patient did not receive treatment for the reported event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of headache was recovered on 13Mar2021.  No follow-up attempts are possible. No further information is expected.
Had body aches, low grade fever, and developed a dry mouth and tickle in my throat, which cause me to keep coughing for 3 days.
CDC reports: 5 yo child w/hx of asthma developed fever, wheezing, screaming episode & limping following DTP/OPV immunization. Duration of illness 5 days.
Pt is a 66 y.o. male admitted with  with a past medical history complicated by cirrhosis secondary to chronic hepatitis-B maintained on entecavir, thrombocytopenia related to splenic sequestration in the setting of cirrhosis, malnutrition, diabetes mellitus on insulin, history SBP currently on prophylaxis with daily doxycycline, and several recent hospitalizations for respiratory failure who presents from home at the discretion of his nurses with his wife for management of further acute onset shortness of breath, fevers.  Received booster on 11/26/21
Dizziness, Myalgia & NauseaVomiting  Narrative:  Per nursing report: "c/o feel nauseated and dizzy. States took 2nd dose of Moderna last Thursday [3/4]. C/o chills and body aches on Friday [3/5] and states throughout the weekend. Requested BP check due to feeling dizzy and nauseated. BP 148/84,p-99.
12/19/17 site was swollen, lump, painless and itchy. (right arm) -size: slightly larger than a quarter.
p/vax pt devel encephalopathy;pt became disoriented, devel renal failure & is comatose;spinal tap showed 32 white cells;fluid sent to lab for dx;
On April 22 I developed pain in my left thigh.  This increased over the next five days and became very debilitating.  On April 28 I developed a rash.  Saw dermatologist who diagnosed shingles.  I had previously had the Shingrix vaccine in 2019.
This case was reported by a healthcare professional and described the occurrence of knee joint pain in a female aged between 30 and 39 years old who was vaccinated with HAVARIX, GlaxoSmithKline, ENGERIX B for prophylaxis. On an unspecified date the subject received a pediatric dose of HAVRIX (.5 ml, unknown) and experienced vaccine under dose. Dose number was unspecified. On an unspecified date the subject received a pediatric dose of ENGERIX B (.5 ml, unknown) and experienced vaccine under dose. Dose number was unspecified. In January 2009 the subject received unspecified dose of ENGERIX B (unknown). Two minutes after vaccination with ENGERIX B the subject experienced knee joint pain which resolved approximately two hours later. The healthcare professional considered the knee joint pain probably related to vaccination with ENGERIX B.
Symptoms began 2 days ago with mildly productive cough and sinus congestion starting 10/12/21
Became unable to swallow and mouth got dry.  Was given Epinephrine, Benadryl and Famotodine.  The symptoms subsided within 2.5 hours.
On 1/6/20 one hour after vaccine, had a headache and mild shortness of breath and fatigue.  On 1/7/20, the shortness of breath worsened, developed muscle aches, headache and fatigue continues, blood pressure became elevated.  Was seen in the Emergency Room.  On 1/11/20 was evaluated by Primary Care Provider.  Blood pressure medications were increased and taken off work until stable.
The vaccine experienced a temperature excursion on 5/10/21 7:05am. Due to this excursion the vaccine was expired when administered. The patient has not experienced any side effects at the time this report was submitted.
Rash and swelling at the injection site. Google reading dubbed it ?COVID arm?. Showed up 8 days after receiving the vaccine
He is on a blood thinner for 10yrs, having a bleeding on his ears; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer (patient) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; FORMULATION: solution for injection, lot number was not reported), via an unspecified route of administration on an unspecified as UNKNOWN, SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient experienced he is on a blood thinner for 10yrs, having a bleeding on his ears on an unspecified date. Outcome of the event was unknown.  Information on the lot/ batch number has been requested.